Evidence map›Paper›PMID 42239787›Full record

ArticleResearch square2026

A Component Analysis of Endotheliopathy of Trauma.

Chavi Rehani, Sarah Abdullah, Karina Rozenberg, Roumen Vesselinov, Jing-Fei Dong, Rosemary Kozar

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chavi RehaniR Adams Cowley Shock Trauma Center.
Sarah AbdullahR Adams Cowley Shock Trauma Center.
Karina RozenbergUniversity of Maryland School of Medicine.
Roumen VesselinovUniversity of Maryland.
Jing-Fei DongBloodworks Research Institute.
Rosemary KozarR Adams Cowley Shock Trauma Center.

Funding

Vascular Biology Training ProgramT32HL007698 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI Rosemary A Kozar, Dudley K. Strickland · 1991 to 2026
$8.7M
Trauma and Shock-Induced Microvascular Dysregulation and CoagulopathyR01GM140983 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI DONG, JING-FEI, KOZAR, ROSEMARY A · 2022 to 2025
$2.4M
NHLBI NIH HHS T32 HL007698NIGMS NIH HHS R01 GM140983
6 · The paper itself

Abstract

Endotheliopathy of trauma (EOT) is a complex response to severe injury involving coagulopathy, platelet dysfunction, endothelial dysfunction, and shock. Although EOT is associated with poor outcomes, the relative contribution of each component is not well defined. This study aimed to determine the impact of individual EOT components on mortality and multiple organ failure (MOF) in severely injured patients. We conducted a single-center prospective observational study from 2022 to 2024 including patients presenting within two hours of injury as a Level 1 trauma activation or with hemorrhage. Demographics, clinical data, and outcomes were collected. Admission blood samples were analyzed for ten biomarkers using a Luminex assay. The primary endpoint was a composite of in-hospital mortality or MOF. Twenty clinical and biomarker variables were grouped into four EOT components. Component-specific multivariable models were developed using ridge regression, and performance was assessed by area under the curve (AUC). Among 159 patients, median age was 39 years, 80% were male, and 42% had penetrating injuries. Median Injury Severity Score was 19, with 15.7% meeting the primary outcome. All component models showed similar predictive performance, highlighting the multifactorial nature of EOT and supporting the need for comprehensive treatment strategies.

Indexed as

coagulopathyendotheliopathyplatelet dysfunctiontrauma

Identifiers

PMID42239787
PMCPMC13228817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.